COVID-19 consumed the world's attention for years, but it was never the only respiratory threat travelers face. Seasonal influenza kills 290,000-650,000 people globally every year. Tuberculosis infected 10.8 million people in 2023. MERS still circulates in the Arabian Peninsula with a case fatality rate of 34%. RSV hospitalizes tens of thousands of adults annually in the US alone.
When you board a plane, you're entering a closed environment with 100-300 strangers who breathed different air 12 hours ago. Knowing which respiratory diseases are active at your destination, and on your route, changes how you prepare.
How dangerous is seasonal influenza for travelers?
Seasonal flu kills more people every year than most pathogens you'd think to worry about, and travel dramatically increases your exposure by putting you in airports, planes, hotels, and crowded spaces alongside people from different hemispheric flu seasons.
WHO estimates 290,000-650,000 respiratory deaths from seasonal influenza per year globally. That range is wide because many flu deaths go uncounted, attributed to pneumonia or cardiac events without testing. For travelers, the risk is compounded by timing.
Flu season in the Northern Hemisphere runs October through March. In the Southern Hemisphere, it peaks April through September. Travel between hemispheres during either peak means arriving into an active flu season your body may not have encountered yet.
A 2014 study in the Journal of Travel Medicine found that influenza was the most common vaccine-preventable infection in travelers, affecting an estimated 1% of travelers per month of travel. That might sound low until you consider the hundreds of millions of international trips taken each year.
Your single best protection: get a flu shot before departure. It takes about 2 weeks for full immunity to develop, so plan accordingly. If you're traveling to the Southern Hemisphere during their winter and you received your flu shot for the Northern Hemisphere season, be aware that circulating strains may differ. Southern Hemisphere vaccines are formulated separately based on WHO recommendations issued each September.
Is RSV really a concern for adults?
RSV hospitalizes approximately 177,000 older adults in the US each year and kills roughly 14,000 of them. Adults over 60 and those with chronic heart or lung disease face the highest risk, yet most travelers don't even consider RSV when planning trips.
For decades, RSV was thought of as a childhood disease. Babies and toddlers filled pediatric wards every winter with bronchiolitis. But surveillance data from the past decade shows that RSV is a significant cause of respiratory hospitalization and death in older adults, rivaling influenza in some seasons.
RSV vaccines for adults aged 60+ became available in 2023 (Arexvy from GSK and Abrysvo from Pfizer). If you're in that age group or have chronic respiratory conditions, vaccination before extended travel, particularly during winter months at your destination, is worth discussing with your doctor. RSV follows seasonal patterns similar to influenza in temperate regions but can circulate year-round in tropical areas.
Crowded travel environments are ideal for RSV transmission. The virus spreads through respiratory droplets and survives on surfaces for several hours. Airports, train stations, and cruise ships are high-contact settings where a single infected person can expose dozens.
Should you worry about TB when traveling?
Tuberculosis remains the world's deadliest infectious disease caused by a single pathogen, killing 1.25 million people in 2023. Travelers to high-burden countries face measurable risk, especially during extended stays.
Eight countries account for two-thirds of global TB cases: India (27% of all cases), Indonesia, China, the Philippines, Pakistan, Nigeria, Bangladesh, and the Democratic Republic of Congo. South Africa has one of the world's highest TB incidence rates per capita. If you're spending weeks or months in any of these countries, your TB exposure risk is real.
Short-term tourists in standard hotels face minimal risk. TB transmission requires prolonged close contact in enclosed spaces, typically many hours. But if your travel involves working in local healthcare facilities, volunteering in shelters, staying in crowded hostels, or spending extended time in poorly ventilated indoor environments, your risk increases substantially.
Drug-resistant TB adds another dimension. Multidrug-resistant TB (MDR-TB) accounts for roughly 3.3% of new TB cases and 17% of previously treated cases globally. Extensively drug-resistant TB (XDR-TB) is even harder to treat, requiring 18-24 months of therapy with toxic second-line drugs. South Africa, Russia, India, and parts of Eastern Europe have the highest MDR-TB rates. An infection you can treat with 6 months of standard antibiotics at home could become a 2-year treatment ordeal if you pick up a resistant strain abroad.
Pre-travel TB skin testing or IGRA blood testing gives you a baseline. If you test negative before departure and positive after return, you know you were exposed during travel and can seek treatment early, before symptoms develop.
What's the MERS risk for travelers to the Middle East?
MERS-CoV has a 34% case fatality rate and still circulates in the Arabian Peninsula, primarily through contact with dromedary camels. Travelers to Saudi Arabia, particularly those attending Hajj or Umrah, face specific risk.
Since its identification in 2012, MERS has caused over 2,600 confirmed cases and 935 deaths across 27 countries. Most cases have originated in Saudi Arabia. Unlike COVID-19, MERS does not spread efficiently between humans in community settings. Most human-to-human transmission has occurred in healthcare facilities. But sporadic zoonotic spillover from camels continues, and the virus's lethality makes every case count.
Hajj brings over 2 million pilgrims to Saudi Arabia annually, creating one of the world's largest mass gatherings. Saudi authorities screen for MERS and other respiratory infections during Hajj, but the sheer density of people in Mecca and Medina creates conditions where any respiratory pathogen can spread rapidly. WHO recommends that Hajj travelers avoid contact with camels and camel products (including raw camel milk and undercooked camel meat), practice frequent hand washing, and wear masks in crowded settings.
If you develop fever, cough, and shortness of breath within 14 days of returning from the Arabian Peninsula, tell your healthcare provider about your travel history immediately. MERS can deteriorate rapidly, and early supportive care improves outcomes.
Is airplane cabin air actually dangerous?
Modern aircraft cabin air is far cleaner than most indoor environments you encounter daily, thanks to HEPA filtration that removes 99.97% of airborne particles, including bacteria and viruses. Air in the cabin is completely replaced every 2-3 minutes.
The risk on planes isn't the air. It's proximity. Passengers within 2 rows of an infectious person face elevated exposure, not because the air is recirculating, but because of direct droplet exposure before air reaches the filtration system. A 2018 study in PNAS found that passengers seated within 1 meter of someone with influenza had an 80% chance of being infected during a transcontinental flight. Beyond that radius, risk dropped to about 3%.
Boarding and deplaning are actually higher-risk periods than cruising altitude. When the plane is on the ground with the ventilation system running at reduced capacity and passengers standing in the aisle, airflow patterns are less effective at clearing respiratory droplets.
Window seats carry the lowest transmission risk, according to the same PNAS study, because window passengers have fewer close contacts during flight. Aisle seats had the most passenger interactions and the highest exposure estimates.
How should you protect yourself?
Practical protection starts well before you reach the airport.
Get vaccinated. Influenza vaccine and RSV vaccine (if you're 60+) are the two most relevant pre-travel shots for respiratory disease. Confirm your COVID-19 boosters are current. These vaccinations won't eliminate risk, but they dramatically reduce your chance of severe illness.
Pack N95 or KN95 masks. Surgical masks reduce exposure somewhat. N95s do it far more effectively, filtering 95% of airborne particles. Wear one in airports, on planes, and in any crowded indoor space where respiratory diseases are circulating at your destination. A handful of masks weigh nothing and fit in any carry-on.
Practice hand hygiene relentlessly. Respiratory viruses spread through contaminated surfaces as well as through the air. Tray tables, armrests, bathroom handles, and luggage carousels are all high-touch surfaces. Alcohol-based hand sanitizer after touching shared surfaces, and before touching your face, cuts your risk substantially.
Check PandemicAlarm before you fly. Active respiratory disease outbreaks at your destination should inform your preparation level. Seasonal flu circulating in Sydney doesn't require the same response as an unusual pneumonia cluster of unknown origin. Review your destination's current outbreak status on PandemicAlarm and consult the outbreak-aware travel guide for a pre-departure checklist.
Know when to mask up at your destination. If you're visiting hospitals, using public transit during peak flu season, attending mass gatherings, or traveling to a region with active TB or MERS transmission, wearing an N95 in those specific settings is a proportionate response, not an overreaction.
Your respiratory system is your most exposed organ system during travel. Protecting it doesn't require paranoia. It requires awareness of what's circulating, a few inexpensive tools, and the willingness to use them when the situation calls for it.